- /
- Supported exchanges
- / US
- / CALC.NASDAQ
CalciMedica, Inc. Common Stock (CALC NASDAQ) stock market data APIs
CalciMedica, Inc. Common Stock Financial Data Overview
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with CalciMedica, Inc. Common Stock (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get CalciMedica, Inc. Common Stock data using free add-ons & libraries
Get CalciMedica, Inc. Common Stock Fundamental Data
CalciMedica, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -23 075 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get CalciMedica, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-03-03
- EPS/Forecast: -0.4125
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CalciMedica, Inc. Common Stock News
New
CalciMedica director Roberts buys $14,708 in company stock
Director Eric W. Roberts of CalciMedica, Inc. (NASDAQ:CALC) recently purchased 5,076 shares of common stock at a weighted average price of $2.8977, in a transaction valued at $14,708. The prices for t...
Hebbar, CalciMedica CMO, buys $16k in CALC stock
CalciMedica, Inc. (NASDAQ:CALC), a small-cap biotech company valued at $42 million, saw Chief Medical Officer Sudarshan Hebbar report purchasing shares of the company’s common stock in two transacti...
CalciMedica (CALC) officer Roberts buys $5,760 in shares
CalciMedica, Inc. NASDAQ:CALC) Chief Business Officer Eric W. Roberts reported purchasing 2,000 shares of common stock on July 18, 2025. The shares were bought at a price of $2.88, totaling $5,760. Th...
Calcimedica (CALC) CEO Leheny buys $6k in stock
CalciMedica, Inc. (NASDAQ:CALC) CEO Leheny A. Rachel reported purchasing 2,500 shares of common stock on July 14, 2025, at a price of $2.47 per share. The total value of the purchase was $6,175. The p...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.